250 related articles for article (PubMed ID: 25117007)
1. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment.
Croci DO; Cerliani JP; Pinto NA; Morosi LG; Rabinovich GA
Glycobiology; 2014 Dec; 24(12):1283-90. PubMed ID: 25117007
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.
Croci DO; Cerliani JP; Dalotto-Moreno T; Méndez-Huergo SP; Mascanfroni ID; Dergan-Dylon S; Toscano MA; Caramelo JJ; García-Vallejo JJ; Ouyang J; Mesri EA; Junttila MR; Bais C; Shipp MA; Salatino M; Rabinovich GA
Cell; 2014 Feb; 156(4):744-58. PubMed ID: 24529377
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.
Bousseau S; Vergori L; Soleti R; Lenaers G; Martinez MC; Andriantsitohaina R
Pharmacol Ther; 2018 Nov; 191():92-122. PubMed ID: 29909237
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
5. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
6. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
Maes H; Olmeda D; Soengas MS; Agostinis P
FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
[TBL] [Abstract][Full Text] [Related]
7. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
8. Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.
Bannoud N; García PA; Gambarte-Tudela J; Sundblad V; Cagnoni AJ; Bach CA; Pérez Saez JM; Blidner AG; Maller SM; Mariño KV; Salatino M; Cerliani JP; Rabinovich GA; Croci DO
Methods Mol Biol; 2022; 2442():635-653. PubMed ID: 35320550
[TBL] [Abstract][Full Text] [Related]
9. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
10. An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans.
Maller SM; Cagnoni AJ; Bannoud N; Sigaut L; Pérez Sáez JM; Pietrasanta LI; Yang RY; Liu FT; Croci DO; Di Lella S; Sundblad V; Rabinovich GA; Mariño KV
FASEB J; 2020 Jan; 34(1):735-753. PubMed ID: 31914594
[TBL] [Abstract][Full Text] [Related]
11. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
12. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.
Willhauck-Fleckenstein M; Moehler TM; Merling A; Pusunc S; Goldschmidt H; Schwartz-Albiez R
Angiogenesis; 2010 Mar; 13(1):25-42. PubMed ID: 20162350
[TBL] [Abstract][Full Text] [Related]
14. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
15. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.
Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA
Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445
[TBL] [Abstract][Full Text] [Related]
16. Galectin-8: a matricellular lectin with key roles in angiogenesis.
Troncoso MF; Ferragut F; Bacigalupo ML; Cárdenas Delgado VM; Nugnes LG; Gentilini L; Laderach D; Wolfenstein-Todel C; Compagno D; Rabinovich GA; Elola MT
Glycobiology; 2014 Oct; 24(10):907-14. PubMed ID: 24939370
[TBL] [Abstract][Full Text] [Related]
17. Tumor vasculature: the Achilles' heel of cancer?
Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
[TBL] [Abstract][Full Text] [Related]
18. Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
[TBL] [Abstract][Full Text] [Related]
19. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
20. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
